Frederic Pla - 06 Nov 2023 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Reporting relationship: Chief Operating Officer
Issuer ticker: AKYA
Reported as of: 06 Nov 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 Nov 2023, 17:41:51 UTC
Prior SEC filing: 11 Sep 2023
Next SEC filing: 01 Mar 2024
Source filing: View source filing
Reporting owner signature: /s/ Frederic Pla, by Brian McKelligon, as Attorney-in-Fact

Key filing fact

Frederic Pla filed Form 4 for Akoya Biosciences, Inc. (AKYA) on 27 Nov 2023.

Key facts

This page summarizes Frederic Pla's Form 4 filing for Akoya Biosciences, Inc. (AKYA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 27 Nov 2023, 17:41.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

Shares, units, or other non-derivative securities reported in this filing.

AKYA transaction

Award

AKYA holding

No transaction description listed

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 2 footnotes

Footnote F1

The restricted stock units shall vest in full on the second anniversary of the first date of the month subsequent to the date of grant.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of Akoya Biosciences, Inc. common stock.